Immunologists have pinpointed how a widely used treatment for non Hodgkin's lymphoma attacks abnormal immune cells, called B cells.
Ads by Google
Drug Clinical Trials
The convenience of a newer formulation of the blood thinner heparin, called enoxaparin, appear to make it the drug of choice for treating patients with suspected heart attacks. Heparin reduces clotting by blocking the action of thrombin.
Leukemia patients who take the anti cancer drug imatinib mesylate (brand-name Gleevec) are at increased risk for developing suppressed immune systems.
Development of drugs to treat a broad array of diseases, including cancer, hypertension, diabetes, inflammation and infectious diseases, could become enormously more effective through the process of "proteome mining."